MediciNova
MNOV
53 hedge funds and large institutions have $48.4M invested in MediciNova in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 9 reducing their positions, and 6 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 9
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
4% more funds holding
Funds holding: 51 → 53 (+2)
1.63% more ownership
Funds ownership: 21.63% → 23.26% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less capital invested
Capital invested by funds: $55.9M → $48.4M (-$7.44M)
57% less call options, than puts
Call options by funds: $151K | Put options by funds: $352K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.26M |
| 2 |
Morgan Stanley
New York
|
+$571K |
| 3 |
D.E. Shaw & Co
New York
|
+$390K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$306K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$236K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.51M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$376K |
| 3 |
AA
ALPS Advisors
Denver,
Colorado
|
-$329K |
| 4 |
Millennium Management
New York
|
-$121K |
| 5 |
EAM
Evanson Asset Management
Carmel,
California
|
-$112K |
MNOV Hedge Fund Activity: Q4 2016 in Review
53 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q4 2016, worth a combined $48.4M — down 13% from $55.9M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new MNOV positions and 6 closed out — a net gain of 3 holders — while 24 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $4.26M. The largest seller was Fidelity Investments, cutting an estimated $2.51M.
- 53 institutional investors held MediciNova (MNOV) as of Q4 2016, up from 51 in Q3 2016.
- Funds reported $48.4M of MediciNova stock for Q4 2016, down 13% quarter-over-quarter.
- 9 funds opened new MediciNova positions in Q4 2016 and 6 closed out, a net change of +3 holders.
- The largest MediciNova buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $4.26M added.
- The largest MediciNova seller in Q4 2016 was Fidelity Investments, an estimated $2.51M sold.
Based on aggregated 13F filings for Q4 2016.